Scientists hailed a new drug for being a “turning point” to slow the progression of Alzheimer’s disease. Donanemab was found to slow “clinical decline” by…
Scientists hailed a new drug for being a “turning point” to slow the progression of Alzheimer’s disease. Donanemab was found to slow “clinical decline” by…